Bujar, M., McAuslane, N., & Liberti, L. (2021). The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested Solutions. Pharmaceut Med.
Citação norma ChicagoBujar, Magdalena, Neil McAuslane, and Lawrence Liberti. "The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested Solutions." Pharmaceut Med 2021.
Citação norma MLABujar, Magdalena, Neil McAuslane, and Lawrence Liberti. "The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested Solutions." Pharmaceut Med 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.